Published in Medical Letter on the CDC and FDA, November 22nd, 2009
The contract between secures the supply of raw pharmaceutical material for HTDS' Mellow Hope in the range of about 4 million dollars. The contract completion is in final stages, and the shipments are already scheduled. This contract is bound to strengthen present and future sales of the raising pharmaceutical...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.